Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henquin, J.-C.
Right arrow Articles by Cerasi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henquin, J.-C.
Right arrow Articles by Cerasi, E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:S1-S2, 2002
© 2002 by the American Diabetes Association, Inc.

Insulin Secretion: Movement at All Levels

Jean-Claude Henquin1, Christian Boitard2, Suad Efendic3, Ele Ferrannini4, Donald F. Steiner5, and Erol Cerasi6

1 Department of Physiology, Endocrinology-Metabolism, Université Catholique de Louvain, Brussels, Belgium
2 INSERM U342, St. Vincent de Paul Hospital, Paris, France
3 Department of Molecular Medicine, Division of Endocrinology & Diabetes, Karolinska Hospital, Stockholm, Sweden
4 Metabolism Unit, CNR Institute of Clinical Physiology, University of Pisa, Pisa, Italy
5 Department of Biochemistry and Molecular Biology and Howard Hughes Medical Institute, University of Chicago, Chicago, Illinois
6 Department of Endocrinology & Metabolism, Hebrew University Hadassah Medical Center, Jerusalem, Israel

With this Second SERVIER-IGIS Symposium Diabetes Supplement, we, the members of the International Group on Insulin Secretion (IGIS), happily realize that we have been able to keep the promise made in the First SERVIER-IGIS Symposium (Diabetes 50 [Suppl. 1], 2001): we are indeed initiating a tradition, with a yearly series of state-of-the-art collections on various aspects of islet biology, with the emphasis on type 2 diabetes. Without the logistics and the generous unrestricted educational grant put at our disposal by SERVIER, Paris, it is doubtful that we would ever embark on this project, let alone succeed in producing these high-quality publications.

The Second SERVIER-IGIS Symposium dealt with the "Kinetics of Insulin Release in Health and Type 2 Diabetes." To optimally fulfill its preeminent role in glucose homeostasis, insulin secretion must not only be quantitatively appropriate, it must also follow a precise time course. It has indeed been known since the 1960s that insulin secretion is phasic; later work refined the definition of phasicity by the discovery of superimposed oscillations of varying frequencies. Many of these features are absent or disturbed in type 2 diabetic patients, sometimes before overt hyperglycemia is established. These convincing findings notwithstanding, the conditions required to demonstrate certain aspects of phasic insulin release are sometimes unphysiological. Just to mention the often used hyperglycemic clamp, in nature the ß-cell is never exposed to a "jump" of the extracellular glucose concentration from 5 to 15–20 mmol/l within 2–3 min. It is therefore a legitimate question whether phasic insulin release is a bona fide biological characteristic of the ß-cell. This supplement examines the question from several angles, at . . . [Full Text of this Article]

ACKNOWLEDGMENTS

FOOTNOTES


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
E. K. de Jong, I. M. Dijkstra, M. Hensens, N. Brouwer, M. van Amerongen, R. S. B. Liem, H. W. G. M. Boddeke, and K. Biber
Vesicle-Mediated Transport and Release of CCL21 in Endangered Neurons: A Possible Explanation for Microglia Activation Remote from a Primary Lesion
J. Neurosci., August 17, 2005; 25(33): 7548 - 7557.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Caumo and L. Luzi
First-phase insulin secretion: does it exist in real life? Considerations on shape and function
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E371 - E385.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.